Pantagraph | Bloomington FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity Central Arizona • Apr 1, 2026
Pantagraph | Bloomington Drugmaker Eli Lilly announces new plant in Pennsylvania as part of broader domestic expansion Central Arizona • Jan 30, 2026
Tri Valley Dispatch Casa Grande Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Central Arizona • May 13, 2025
Pantagraph | Bloomington European committee says Lilly Alzheimer's drug shouldn't get marketing approval Central Arizona • Mar 28, 2025
Pantagraph | Bloomington Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound Central Arizona • Dec 6, 2024
Pantagraph | Bloomington Eli Lilly's third quarter earnings miss and forecast cut lead to sharp stock drop Central Arizona • Oct 30, 2024
Pantagraph | Bloomington Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter Central Arizona • Aug 8, 2024
Pantagraph | Bloomington WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs Central Arizona • Jun 20, 2024
News Herald Lake Havasu City A new drug could slow Alzheimer's. But can patients get it? Western Arizona • Jun 17, 2024
Pantagraph | Bloomington Alzheimer's drug that can slow disease gets backing from FDA advisers Central Arizona • Jun 11, 2024
Pantagraph | Bloomington Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro Central Arizona • May 24, 2024
Pantagraph | Bloomington Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues Central Arizona • Apr 30, 2024
Williams News Analyst revamps Eli Lilly stock price target on weight loss drug Northern Arizona • Mar 19, 2024
Tucson .com | Arizona Minnesota and Eli Lilly settle insulin price-gouging lawsuit. Deal will hold costs to $35 a month Arizona • Feb 7, 2024
Pantagraph | Bloomington Minnesota and Eli Lilly settle insulin price-gouging lawsuit. Deal will hold costs to $35 a month Central Arizona • Feb 7, 2024
Verde News | Cottonwood Eli Lilly leaps as weight-loss-drug sales drive earnings and 2024 outlook Northern Arizona • Feb 6, 2024
Verde News | Cottonwood Novo Nordisk, Eli Lilly leap as Ozempic show promise in kidney patient treatment Northern Arizona • Oct 11, 2023
Pantagraph | Bloomington Soaring sales of diabetes drug Mounjaro, often used for weight loss, sends Eli Lilly to new heights Central Arizona • Aug 8, 2023